COMPANY

Oryzon Genomics

oryzon.com ↗ · New England

Keywords: neurology oncology hematology

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Undisclosed round · $12M (converted from EUR) · announced Jul 1, 2026 Company release ↗
Source quote
- Jul 1, 2026 · Company release ↗
  “(ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced the successful completion of a €12 million gross capital increase through the issuance of 4,444,445 new ordinary shares, at a subscription price of €2.70 per share.”

From the company’s own releases; this list is partial. All raises and deals